With the objective of determining the causative factors underlying drug side effects, a pharmacoepidemiological study was conducted using three injection drugs, cefotaxime, cefoperazone and latamoxef, which in Japan, are referred to as third-generation cephem antibiotics. An analytical investigation of 150 items, including medicated drugs and bioinformation, was conducted on the medical records of 600 hospitalized patients, all of whom had been administered one of these injection drugs.
Introduction
The importance of medication history has been raised recently with current opinion pointing to an apparent need to analyze and evaluate the accumulated medication bistory together with a variety Yazako, Nagakute-cho, Aichi-ken, 480.11 Japan SalEae-choi Itabashi-ku, Tokyo, 173 Japan of bioinformation on a patient using epidemiologic techniques. Pharmacoepidemiology, which is an example of this epidemiologic approach, is a field of medical science that aims at effectively reducing the data and information obtained from observation of a patient population for application to individual pharmacotherapy1,2).
Using cephem antibiotics the authors conducted a pharmacoepidemiological investigation to elucidate the causative factors specific to a side-effect positive patient group, and have reported the results of univariate analysis elsewhere). In the present study, several factors were considered simultaneously and a multivariate analysis was conducted in order to investigate the degree of association of these factors with the development of drug-administration side effects. Moreover, using the factors identified to have a close association with the development of drug-administration side effects, the authors derived a predictive formula of side effect manifestation to estimate the probability that side effects will occur. The authors report here the results of using the formula to estimate the probability of side effects.
Subjects and Methods
An analytical survey was conducted on 150 items, including the patient's general background factors, habits, medication-related factors of the antibiotics under investigation, the status of manifestation of side effects, and the laboratory test data before drug administration documented in the hospital records of the patients who were given any of the three injection drugs, cefotaxime, cefoperazoneand latamoxef, which in Japan, are referred to as third-generation cephem antibiotics, during the one-year between March 1982 and February 1983. The subjects of the analysis included 600 randomly selected patients accounting for around 50% of 1,196 hospitalized patients who had been administered one of the injection drugs under investigation. As shown in Table 1 , these subjects consisted of 318 males and 282 females3).
In the present survey, signs and symptoms of the side effects which were common among the three antibiotics under investigation were checked. The side effects were seen as shock, hypersensitivity, hemorrhage, stomatitis, glossitis, candidiasis, headache, anorexia, neuritis, general malaise, diarrhea, nausea, and vomiting. These signs and symptoms of side effects occur commonly with administration of any of the three antibiotics under investigation. The authors defined side effects as the manifestation of adverse signs and symptoms that were first described in the hospital records after ad- 
Principal component analysis (factor analysis)
Principal component analysis was conducted to classify these 11 variables (factors). Tables 3 shows the result of this analysis. These 11 factors were classified into the categories of the first to the fifth factor (numerical values underlined in Table 3 ). Combined together, these factor groups were found to be associated with the side effects. Cancer disease-related factors were extracted as the first factor, host-factors as the second factor, and drug-related factors as the third factor. The types of drugs under investigation and eosinophil were respectively extracted as the fourth and the fifth factors independently.
Akaike-Minimum-AIC method
The following five factors were selected from the aforementioned 11 factors as representative variables from which information may be effectively obtained by Akaike-Minimum-AIC method:
(1) total administration dosage of the relevant antibiotics of more than 11g
(2) abnormal leukocyte counts before administration of the drugs under investigation Table 4 illustrates a predictive formula of manifestation of side effects according to the multivariate logistic analysis using the above-described 5 variables (factors) extracted by the Akaike-Minimum-AIC method. The probability of manifestation of side effects estimated from this predictive for- mula, that is, the expected value, was consistent with the observed result. The probability of manifestation of side effects in patients having a single factor was 10.7% for cancer disease, 14.1% for the total administration dose of more than 11g of the antibiotics under investigation, 22.9% for the abnormal leukocytes, and 23.9% for intravenous injection (excluding drip administration). When 4 factors such as cancer disease, total administration dose, leukocytes, and concurrent use of drugs with a hemorrhage-inducing tendency were combined together, the probability of manifestation of side effects was as high as 75.9%. Table 4 shows the relative risk of developing side effects using the formula when a group free from any of these 5 factors was used as a standard. The relative risk in patients possessing a single factors was 2.9 for cancer disease, 3.1 for a total administration dose of more than 11g of the antibiotics under investigation, 7.7 for the presence of abnormal leukocytes, and 9.6 for intravenous injection (excluding drip administration). Similarly, it was shown that the relative risk was higher with combined factors. When these 4 factors were combined, the relative risk of developing drug-administration side effects was found to be as high as 67.
Discussion
Using three injection drugs, cefotaxime, cefoperazone and latamoxef, which in Japan, are referred to as third-generation cephem antibiotics, the authors conducted an analytical epidemiologic study on the causative factors of drug side effects of these antibiotics by linking the patients' prescriptions and medical records3). These three agents have been observed to induce almost identical side effects. The authors believe that clarification of the causative factors, which should be referred to as risk factors for the development of side effects, may provide useful information for the effective use of pharmacotherapy.
Investigation of the internal correlation between the highly significant factors, which were identified from the result of univariate analysis, revealed a reciprocal close relation between the factors. In our view, investigation of the correlation between individual factors (risk factors) and side effects fails to disclose the degree of association between the individual factors and the side effects. According, the authors conducted a multivariate analysis in order to analyze the relation between various factors and side effects concurrently. The result of principal component analysis (factor analysis) showed that certain groups of factors were associated with the side effects. From the result of the Akaike-Minimum-AIC method, it was revealed that the 5 factors including total administration dose, leukocyte counts, method of administration, cancer disease, and combined use of drugs with a hemorrhage-inducing tendency are the most useful in explaining the mechanism of occurrence of side effects. The authors prepared a predictive formula of side effect manifestation according to the multivariate logistic analysis using these 5 factors and used it to estimate the probability of side effect manifestation.
For example, when the aforementioned 5 factors were not applicable, such as in the case of a total administration dose of less than 10g, normal leukocytes, drip or intramuscular injection, absence of cancer disease, and no use of drugs with a hemorrhage-inducing tendency, the estimated probability of side effect manifestation (P) was such that Accordingly, the probability of side effect manifestation (P) was However, with an increase in the number of superimposed factors, the manifestation of side effects increased,
In the present study drug administration by intravenous injection, total administration dosage of more than 11g, concurrent use of antineoplastic agent, and drugs associated with a hemorrhagic tendency were, found to be the main causative factors underlying the appearance of side effects of the three antibiotics under investigation. The respective clinical dosages of the three antibiotics under investigation were equivalent. The frequency of total dosage of less than 10g was significantly rare in the side-effect-positive group, on the contrary, total dosage of more than 40g was significantly high in the side-effect-positive group by univariate analysis3). There was a tendency for a low frequency of intramuscular injection and drip therapy, but a high frequency of intravenous injection in the sideeffect-positive group3).
The following host-related factors were also found to have a causal relationship with side effects:(1) a decrease in leukocyte counts, which possibly indicates a decrease in lymphocyte counts and suggests a decreased immunological capacity7), (2) a decrease in the total cholesterol level may indicate a decrease in the matrix of the organic cell membrane components, various steroid hormones and bile acids7), also suggesting a decreased immunological capacity, (3) a decrease in platelet counts, suggesting myelosuppression and decreased coagulability8). However, the above-mentioned host-related factors can also be regarded as a reflection of the influence of cancer disease and the administration of antineoplastic agents. Considering these factors at the same time, the authors carried out a multivariate analysis.
The incidence of side effects on cefotaxime, cefoperazone, and latamoxef have been reported 2.38%9), 3.59%10), and 2.40%11), respectively. But the incidence of side-effect-positive patients of the drugs under investigation were 11.9%, 33.1%, and 21.8%, correspondingly; indicating the fivefold to tenfold increase in this study. The authors defined side effects as the manifestation of adverse signs and symptoms that were first described in the hospital records after administration of the specific drugs under investigation and not those specified by the attending doctors as "side effects".
During the administration of a drug, it is difficult to eliminate the factors of abnormal leukocyte count and the existence of cancer disease, both of which are host factors. However, if these factors are observed in a patient, it is still possible to reduce, to some extent, the incidence of side effects if the total administration dosage and method of administration, which are drug-related factors, are taken into account on the basis of the results of this predictive formula. In the present study, the side effects induced by the drugs under investigation were considered in combination. Future investigations should also address the causative factors of side effects in accordance with their individual signs and symptoms, such as for example, the major side effect of bleeding.
In recent years, pharmacokinetics-based monitoring of blood concentration by measuring drug blood concentration has allowed patient-specific control of the optimum administration dosage. Furthermore, it has been demonstrated that with an increase in the blood concentration over a certain dose, the manifestation of adverse reactions increases, thereby raising the importance of measuring the drug blood concentration from the viewpoint of avoiding side effects. In order to safely administer a drug with an expected therapeutic effect, adequate analysis of both the host-factors and drug-factors is required12). Very often in actual medical management, several drugs are used in combination, and particular caution on the drugs to be combined is needed. In this case, it is of value to analyze the accumulated bioinformation of a number of patients at Phase IV after the release of the drugs on the market, as performed in the present study. Accordingly, the authors designed the predictive formula of side effect manifestation using the host-factors and drug-factors obtained from the present study to estimate the probability of side effects occurring and allow the causative factors to be eliminated and side effects to be avoided.
In Japan, pharmacopredictology based on pharmacokinetics has been proposed recently as a new field of medicine13). Pharmacopredictology is a science which deals with intra-corporeal pharmacokinetics, pharmaceutical efficacy, and side effects. It is a field of study aimed at obtaining the maximum therapeutic effect with minimum side effects through pharmaco-therapy. Similarly, pharmacoepidemiology is a region of study aimed at determining the therapeutic effects and side effects of drugs in a subject population using epidemiologic techniques in order to administer the optimum pharmacotherapy to each patient2). Pharmacoepidemiology is considered to contribute to pharmaceutical care by applying the information obtained from a population to individuals. Therefore, a tight linkage between the sciences of pharmacoepidemiology and pharmacopredictology to predict side effects may further provide therapeutic benefit to individual patients13).
In the present study, the authors obtained a variety of information from patient prescriptions and medical records. However, since preexisting documents such as medical records inherently entail inconstant descriptions and omissions of some descriptions, there is a limitation to the usefulness of such documents. Currently in Japan, a consultation fee of 6,000 yen per month is approved as the health insurance medical fee for bedside medical consultation of hospitalized patients by a pharmacist. This ward activity of the hospital pharmacy is now practiced at many hospitals. In order to achieve further progress in the field of pharmacoepidemiology, an essential activity will be to build up a data base of medication history and bioinformation obtained from the ward consultations of phar-
macists. An example is the Boston Collaborative Drug Surveillance Program (BCDSP)14-17) which analyzed the accumulated information of monitored medications and medical events of hospitalized patients. It is expected that in Japan, a system based on the BCDSP will be developed in the course of continuing ward activities by pharmacists.
Conclusion
Using antibiotics, the authors accumulated the medication history and bioinformation from patient's prescriptions and medical records, and identified the factors specific to a side-effect-positive group of patients. Selected factors from the result of univariate analysis were closely interrelated.
The authors then conducted a multivariate analysis to analyze numerous factors together at the same time. According to the Akaike-Minimum-AIC method, 5 factors were selected as the most helpful factors to explain the development of side effects of the relevant antibiotics. A predictive formula of manifestation of side effects according to the multivariate logistic analysis was derived using these 5 factors. Information obtained from an epidemiologic analysis of a patientpopulation will contribute to pharmacotherapy in individual patients.
